Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

Alison M. MacLeod · Kidney International · 2009 · 2.2K citations

Medicine, Nephrology, Pharmacotherapy +16

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

Tamara Isakova, Patricia Wahl, Gabriela Vargas et al. · Kidney International · 2011 · 1.2K citations · Full text

Medicine, Endocrinology, Nephrology +16

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

Tamara Isakova · JAMA · 2011 · 1K citations · Full text

Medicine, Molecular Medicine, Nephrology +11

Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease

Danilo Fliser, Barbara Kollerits, Ulrich Neyer et al. · Journal of the American Society of Nephrology · 2007 · 694 citations

Medicine, Endocrinology, Nephrology +16

Effects of Phosphate Binders in Moderate CKD

Geoffrey A. Block, David C. Wheeler, Martha S. Persky et al. · Journal of the American Society of Nephrology · 2012 · 540 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17